Jade Biosciences Announces Pricing of Public Offering of Common Stock
Jade Biosciences priced a public offering of 10 million shares at $15.00 per share, generating gross proceeds of $150 million. The underwriters hold a 30-day option to purchase up to 1.5 million additional shares, which would bring total potential proceeds to $172.5 million.
Key figures
- Deal Value Usd
- 150000000
- Offering Price
- 15
- Shares Offered
- 10000000
- Overallotment shares
- 1500000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.